Kimia Biosciences has informed that in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and Company's Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the Trading Window for dealing in the Equity Shares of the Company by Designated Persons (and their immediate relatives) shall remain closed from Friday, 1st April, 2022 up to the completion of 48 hours after the declaration of unaudited Financial Results of the Company for the 4th quarter ended 31st March 2022 to the Stock Exchange.
The above information is a part of company’s filings submitted to BSE.
